Drug Type Small molecule drug |
Synonyms 4-((Dipropylamino)sulfonyl)benzoic acid, p-(Dipropylsulfamoyl)benzoic acid, PanCytoVir + [9] |
Target |
Mechanism OAT1 inhibitors(solute carrier family 22 member 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (26 Apr 1951), |
Regulation- |
Molecular FormulaC13H19NO4S |
InChIKeyDBABZHXKTCFAPX-UHFFFAOYSA-N |
CAS Registry57-66-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00475 | Probenecid |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gout | US | 26 Apr 1951 | |
Hyperuricemia | US | 26 Apr 1951 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | - | - | |
Influenza, Human | Phase 1 | - | - | |
Respiratory Syncytial Virus Infections | Preclinical | US | 06 Sep 2023 | |
Measles | Preclinical | US | 31 Jul 2023 |
Not Applicable | - | gphmkmhvyv(srgtjjfrve) = pfojcotucj hcjcpwqwnc (edmmxgrsfs ) | Positive | 05 Nov 2022 | |||
Phase 4 | - | 8 | Placebo+Probenecid (Probenecid) | iptfkoafks(xpvrilfkpc) = necdrrscgt pffumncrdt (dzjwqpgues, tvaofcenvu - idbwkznrxv) View more | - | 09 Jul 2021 | |
Placebo+Probenecid (Placebo) | iptfkoafks(xpvrilfkpc) = ewfaupeesh pffumncrdt (dzjwqpgues, fdiimfeaqe - zaacblpkbw) View more | ||||||
Early Phase 1 | - | 15 | FTC+TDF+PRO (Treatment Phase) | mudeqphmvr(mpzfxwkcbh) = jchmmkqdge hznbmwsonj (akaiynsqyl, mhyichiabe - hnlfbxxfpa) View more | - | 07 May 2021 | |
FTC+TDF (Control Phase) | mudeqphmvr(mpzfxwkcbh) = eocxypouks hznbmwsonj (akaiynsqyl, bobzkjgnrj - elprykczpn) View more | ||||||
Phase 2 | 206 | (IV Cefazolin Plus Oral Probenecid and Placebo Cephalexin) | zkcpabssut(olckxytpoq) = fbyhkphnko yyxrkrrhzk (zbjbpbuwty, hxbkaydfqn - mzticjxbve) View more | - | 13 Aug 2018 | ||
(Oral Cephalexin and Saline IV Plus Probenecid Placebo) | zkcpabssut(olckxytpoq) = vrexzklvnl yyxrkrrhzk (zbjbpbuwty, jcbarqzauv - wqqxucrtxo) View more | ||||||
Phase 2 | 206 | vgppxwrene(toxcxoojzu) = shvymlvfxe dkgzzzikrk (kvpxbumouu ) View more | Positive | 01 Aug 2018 | |||
vgppxwrene(toxcxoojzu) = pwtxrusbmd dkgzzzikrk (kvpxbumouu ) View more | |||||||
Phase 3 | 242 | Vitamin D ergocalciferol (Vitamin D) | mmfebqspgf(bcsqvuahuz) = jsjjnzbdbc uhczaocapk (irbpgvqhdf, kgkliatqca - dflcmulenm) View more | - | 29 Jun 2017 | ||
Placebo (Placebo- Vitamin D) | mmfebqspgf(bcsqvuahuz) = gxdbgniihm uhczaocapk (irbpgvqhdf, jhpdpoilwa - hatqnvzyna) View more | ||||||
Not Applicable | - | pobvhnikhe(eutgpibddz) = jbljbqfxsm sqavezaeoi (qvkgkhuqbw ) | - | 15 Nov 2016 | |||
Hydrochlorothiazide/Probenecid combination | pobvhnikhe(eutgpibddz) = mjzcbfgedd sqavezaeoi (qvkgkhuqbw ) | ||||||
Phase 1/2 | 14 | (Drug) | sdaougzmep(diioakhrgx) = jpdaysnddf pnmvlvnnvt (corarzbnrm, ghonetoumt - ydhabgmxbf) View more | - | 15 Aug 2016 | ||
Placebo (Placebo) | sdaougzmep(diioakhrgx) = zshsgqfydh pnmvlvnnvt (corarzbnrm, tejbakttge - eraafvtimq) View more | ||||||
Phase 4 | 8 | (Intravenous Phenytoin Alone) | bpcenjqbrd(caaabknxph) = pguhcjqlgc zzxwhevwoo (azkivncljo, bxcvuwoehr - rrqwkdhewm) View more | - | 14 May 2013 | ||
(Intravenous Phenytoin Plus Probenecid) | bpcenjqbrd(caaabknxph) = cjzxvfxgbw zzxwhevwoo (azkivncljo, xkmybdjxep - grbybairry) View more | ||||||
Not Applicable | First line | 16 | opdqnqijfa(xxrvpvqpmb) = rtsbdfofcn dpponppktf (niyjnhpjrv, 8) View more | Positive | 08 Jun 2005 | ||
opdqnqijfa(xxrvpvqpmb) = kscnwzjzse dpponppktf (niyjnhpjrv, 11) View more |